fashion -WSS

fashion

author：comprehensive 2025-09-29 21:15:03 - browse：42381

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Why ADHD is under

hotspot

WSS

NIH fellows want a pay raise. Will that mean less money for grants?

Living with Fabry disease, a condition that causes chronic pain

Intermittent fasting comes with a heart risk? Not so fast

Beach reads and more: STAT's 2023 summer book list

U.K. researchers warn about biases in medical devices, algorithms

Stop the failed accountable care organization experiment

entertainment

fashion

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Neuroscience’s long legacy of racism

The cancer drug shortage isn’t new — and neither are the solutions

Virtual Event: March of the Biosimilars

Trump demands the U.S. pay no more for drugs than other countries … again

NIH fellows want a pay raise. Will that mean less money for grants?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Oak trusses raised to roof of fire

Novavax promises a turnaround & Lilly roils the obesity market

Creating egg and sperm cells from stem cells raises ethical issues

focus

Living with Fabry disease, a condition that causes chronic pain

New research casts further doubt on a common procedure used with IVF

A new study sees potential in DNA sequencing of infants

Biden launches a new push to limit health care costs

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

hotspot

hotspot

hotspot

hotspot